Clinical Trial

FINE-START: Efficacy and Safety of Finerenone in Patients With Chronic Kidney Disease Not Using Renin-angiotensin-system Inhibitors

Study acronym: FINE-START
Enrolling by Invitation Phase 3
View on ClinicalTrials.gov →
Summary
Study to demonstrate efficacy of finerenone when compared to placebo in reducing albuminuria in participants with chronic kidney disease (CKD) not using renin-angiotensin-system (RAS) inhibitors.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-09-16; most recent amendment 2026-04-13.
Status change: Not Yet Recruiting → Enrolling by Invitation 2026-03-26
Trial Details
NCT Number NCT07181135
Lead Sponsor University Medical Center Groningen
Conditions Chronic Kidney Disease
Enrollment 180 participants
Start Date 2026-03-13
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-14